Sofia Dilruba, Zhou Qilu, Shahriyari Leili
Department of Mathematics and Statistics, University of Massachusetts Amherst, Amherst, MA 01003, USA.
Bioengineering (Basel). 2023 Nov 16;10(11):1320. doi: 10.3390/bioengineering10111320.
This review explores the multifaceted landscape of renal cell carcinoma (RCC) by delving into both mechanistic and machine learning models. While machine learning models leverage patients' gene expression and clinical data through a variety of techniques to predict patients' outcomes, mechanistic models focus on investigating cells' and molecules' interactions within RCC tumors. These interactions are notably centered around immune cells, cytokines, tumor cells, and the development of lung metastases. The insights gained from both machine learning and mechanistic models encompass critical aspects such as signature gene identification, sensitive interactions in the tumors' microenvironments, metastasis development in other organs, and the assessment of survival probabilities. By reviewing the models of RCC, this study aims to shed light on opportunities for the integration of machine learning and mechanistic modeling approaches for treatment optimization and the identification of specific targets, all of which are essential for enhancing patient outcomes.
本综述通过深入研究机制模型和机器学习模型,探索肾细胞癌(RCC)的多方面情况。机器学习模型通过各种技术利用患者的基因表达和临床数据来预测患者的预后,而机制模型则专注于研究肾细胞癌肿瘤内细胞和分子的相互作用。这些相互作用尤其围绕免疫细胞、细胞因子、肿瘤细胞以及肺转移的发生发展。从机器学习模型和机制模型中获得的见解涵盖了关键方面,如特征基因识别、肿瘤微环境中的敏感相互作用、其他器官中的转移发展以及生存概率评估。通过回顾肾细胞癌模型,本研究旨在阐明整合机器学习和机制建模方法以优化治疗和识别特定靶点的机会,所有这些对于改善患者预后都至关重要。